3-Isopropyl-4-methyl-pentanoic acid 2-hydroxymethyl-4-(3-isobutyl-5-methyl-hexylidene)-5-oxo-tetrahydro-furan-2-ylmethyl ester

ID: ALA138171

PubChem CID: 11026526

Max Phase: Preclinical

Molecular Formula: C26H46O5

Molecular Weight: 438.65

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)CC(C/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)CC(C)C

Standard InChI:  InChI=1S/C26H46O5/c1-17(2)11-21(12-18(3)4)9-10-22-14-26(15-27,31-25(22)29)16-30-24(28)13-23(19(5)6)20(7)8/h10,17-21,23,27H,9,11-16H2,1-8H3/b22-10+

Standard InChI Key:  PKVDZHIWRHABMS-LSHDLFTRSA-N

Molfile:  

     RDKit          2D

 31 31  0  0  0  0  0  0  0  0999 V2000
    4.5167  -10.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2625  -11.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8500  -10.0625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1875  -10.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7500  -12.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4375  -11.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5250   -7.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5292   -9.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9417   -8.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3042  -10.2917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7042   -9.1167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9417   -9.8292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7667   -9.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4125  -12.7542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9375   -6.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7000   -7.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8917  -13.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5542  -14.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7167  -13.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6000  -11.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8042  -10.9125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0542  -12.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7375  -14.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7625   -6.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5167   -6.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2875   -6.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -8.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8750  -12.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5667  -11.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4042  -15.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2542  -13.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  1  0
  5  2  2  0
  6  2  1  0
  7  9  1  0
  8 12  1  0
  9  8  1  0
 10  1  2  0
 11  8  2  0
 12 13  1  0
 13  4  1  0
 14  5  1  0
 15  7  1  0
 16  7  1  0
 17 14  1  0
 18 17  1  0
 19 17  1  0
 20  4  1  0
 21 20  1  0
 22 19  1  0
 23 18  1  0
 24 15  1  0
 25 15  1  0
 26 16  1  0
 27 16  1  0
 28 22  1  0
 29 22  1  0
 30 23  1  0
 31 23  1  0
  4  6  1  0
M  END

Associated Targets(Human)

PRKCA Tchem Protein kinase C alpha (5923 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

W4 (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 438.65Molecular Weight (Monoisotopic): 438.3345AlogP: 5.55#Rotatable Bonds: 13
Polar Surface Area: 72.83Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.69CX LogD: 6.69
Aromatic Rings: Heavy Atoms: 31QED Weighted: 0.30Np Likeness Score: 1.39

References

1. Lee J, Han KC, Kang JH, Pearce LL, Lewin NE, Yan S, Benzaria S, Nicklaus MC, Blumberg PM, Marquez VE..  (2001)  Conformationally constrained analogues of diacylglycerol. 18. The incorporation of a hydroxamate moiety into diacylglycerol-lactones reduces lipophilicity and helps discriminate between sn-1 and sn-2 binding modes to protein kinase C (PK-C). Implications for isozyme specificity.,  44  (25): [PMID:11728178] [10.1021/jm0103965]
2. Lee J, Kang JH, Han KC, Kim Y, Kim SY, Youn HS, Mook-Jung I, Kim H, Lo Han JH, Ha HJ, Kim YH, Marquez VE, Lewin NE, Pearce LV, Lundberg DJ, Blumberg PM..  (2006)  Branched diacylglycerol-lactones as potent protein kinase C ligands and alpha-secretase activators.,  49  (6): [PMID:16539391] [10.1021/jm0509391]

Source